Form D Explorer

Form D — NLS Pharmaceutics Ltd.

0001213900-25-031562 · filed 2025-04-14

Offering

Industry
Pharmaceuticals
Exemptions
06b
Total offering
$2,000,000
Total sold
$2,000,000
Minimum investment
$0
Investors
Sales commission
Finders' fees

Issuer

Name
NLS Pharmaceutics Ltd.
CIK
1783036
Entity
Other
Jurisdiction
SWITZERLAND
Year incorporated
Address
THE CIRCLE 6
ZURICH, V8 8058
Phone
+41.44.512.2150

Related persons

View original on SEC EDGAR.